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Prostaglandins are known to lower activation threshold to 
thermal, mechanical, and chemical stimulation in small-di- 
ameter sensory neurons. Although the mechanism of pros- 
taglandin action is unknown, agents known to elevate intra- 
cellular calcium produce a sensitization that is similar to that 
produced by prostaglandins. Consistent with the idea of 
prostaglandin-induced elevations in calcium, prostaglandins 
might also stimulate the release of neurotransmitter from 
sensory neurons. We therefore examined whether prosta- 
glandin E, (PGE,) could enhance the release of the putative 
sensory transmitter substance P (SP) from isolated neurons 
of the avian dorsal root ganglion grown in culture. Utilizing 
the whole-cell patch-clamp recording technique, we also ex- 
amined whether POE, could alter calcium currents in these 
cells. Exposure of sensory neurons to PGE, produced a dose- 
dependent increase in the release of SP. One micromolar 
POE, increased release approximately twofold above basal 
release, whereas 5 and 10 PM PGE, increased release by 
about fourfold. The release evoked by these higher concen- 
trations of POE, was similar in magnitude to the release 
induced by 50 mM KCI. Neither arachidonic acid (10 PM), 
prostaglandin F, (10 PM), nor the lipoxygenase product leu- 
kotriene 6, (1 PM) significantly altered SP release. The ad- 
dition of 1 FM PGE, increased the peak calcium currents by 
1.8-fold and 1.4-fold for neurons held at potentials of -80 
and -90 mV, respectively. The action of PGE, was rapid with 
facilitation occurring within 2 min. As with release studies, 
arachidonic acid, prostaglandin Fza, and leukotriene B, had 
no significant effect on the amplitude of the calcium current. 
These results suggest that PGE, can stimulate the release 
of SP through the activation or facilitation of an inward cal- 
cium current. The capacity of PGE, to facilitate the calcium 
current in these sensory neurons may be one mechanism to 
account for the ability of prostaglandins to sensitize sensory 
neurons to physical or chemical stimuli. 
Prostaglandins (PGs) appear to be important mediators in- 
volved in lowering the pain threshold during tissue injury and 
inflammation, that is, in producing hyperalgesia. Injection of 
PGE, or PGI, into the hind paw of the rat or into the knee joints 
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of dogs produces hyperalgesia as indicated by a lowering of the 
pressure necessary to elicit a withdrawal or by the degree ofjoint 
incapacitation, respectively (Willis and Cornelsen, 1973; Fer- 
reira et al., 1978; Taiwo and Levine, 1989). In humans, PGs in 
micromolar concentrations intensify bradykinin- or histamine- 
induced pain (Ferreira, 1972). In addition, the accepted mech- 
anism for pain relief produced by aspirin and other nonsteroidal 
antinflammatory drugs is the inhibition of cyclooxygenase, the 
enzyme that catalyzes the conversion of arachidonic acid to PGs 
(Collier, 1971; Smith and Willis, 1971; Vane, 1971). 
Presumably, PG-induced hyperalgesia involves a direct action 
of these eicosanoids on sensory neurons. PGE, and PGE, sen- 
sitize small-diameter sensory nerve fibers to thermal and me- 
chanical stimulation (Handwerker, 1976; Pateromichelakis and 
Rood, 1982; Martin et al., 1987) and facilitate activation of 
these neurons by potassium, capsaicin, and bradykinin (Chahl 
and Iggo, 1972; Baccaglini and Hogan, 1983; Yanagisawa et al., 
1986; Schaible and Schmidt, 1988). Although the cellular mech- 
anisms for the action of PGs on sensory neurons remain un- 
known, early studies suggested that calcium may have an im- 
portant regulatory role. Agents that are known to alter the 
intracellular concentration of calcium produce hyperalgesia that 
is similar to that produced by PGE, (Ferreira and Nakamura, 
1979). In addition, recent studies utilizing bovine chromaffin 
cells and NG108-15 neuroblastoma-glioma hybrid cells dem- 
onstrate that PGE, facilitates the entry of calcium through ac- 
tivation of neuronal membrane calcium channels (Koyama et 
al., 1988; Miwa et al., 1988; Mochizuki-Oda et al., 1991). 
Consistent with this enhanced influx of calcium, it is possible 
that PGs could initiate the release of neurotransmitter from 
sensory neurons. The enhanced release of neurotransmitter could 
in turn contribute to PG-induced hyperalgesia and to PG-in- 
duced inflammatory responses. Ueda et al. (1985) and Uda et 
al. (1990) have proposed that enhanced release of one putative 
sensory neurotransmitter, substance P (SP), by PGs could be 
the mechanism to explain the PG-induced hyperalgesia and PG- 
induced potentiation ofthe stimulated contraction ofiris sphinc- 
ter muscle. To date, however, no studies have been performed 
to determine if PGs actually stimulate transmitter release from 
sensory neurons. 
We sought to examine whether PGE, or other eicosanoids 
could alter the release of SP from avian sensory neurons grown 
in culture. Our studies indicate that PGE, can enhance the re- 
lease of SP from avian sensory neurons grown in culture. In 
contrast, neither PGF,,, arachidonic acid, nor the lipoxygenase 
metabolite leukotriene B, (LTB,) has any significant effect on 
release. To examine a possible mechanism for the enhanced 
release of SP, we utilized the whole-cell patch-clamp technique 
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(Hamill et al., I98 1) to examine the actions of PGE, and other 
eicosanoids on calcium currents in these sensory neurons. PGE, 
enhanced the voltage-dependent calcium current, suggesting that 
the facilitated calcium current might be responsible for increas- 
ing release of SP. Again, neither PGF,,, arachidonic acid, nor 
LTB, had any significant effect on calcium currents. 
Preliminary findings from these studies have appeared in ab- 
stract form (Vasko et al., 1989; Nicol and Vasko, 199 1). 
concentration of acetic acid is 2 N. In each experiment, a number of 
wells were used as controls and consisted of the measurement of the 
basal release and the release induced by high extracellular potassium. 
If potassium did not evoke the release of SP, the experiment was dis- 
carded. Neither vehicle, ethanol, nor I-methyl-2-pyrrolidinone, at the 
concentrations used in the eicosanoid experiments, had any effect on 
either the basal or potassium-stimulated release of SP. For experiments 
involving indomethacin, cells were incubated in Krebs’ buffer contain- 
ing IO &ml indomethacin for 30 min prior to initiating the release 
protocol. 
After collection of the release solutions, the samples were lyophilticd 
Materials and Methods 
Experiments were performed using primary cultures of neurons har- 
vested from the dorsal root ganglia (DRG) of 8-10 d old chicken em- 
bryos. Eicosanoids were purchased from Cayman Chemical Co. (Ann 
Arbor, Ml), peptides from Peninsula Laboratory (Belmont, CA), nerve 
growth factor from Collaborative Biochemical Products Inc. (Bedford, 
MA), other supplies for culture medium from GIBCO Laboratories 
(Grand Island, NY), and routine chemicals from Sigma Chemical Com- 
pany (St. Louis, MO). 
Cell culture. Avian dorsal root ganglia neurons were harvested and 
grown using a modification of the method of Dichter and Fischbach 
( 1977). Briefly, fertilized chicken eggs were incubated for 8-l 0 d at 39°C. 
Embryos were removed and DRG dissected out. The ganglia were placed 
in a calcium-free, magnesium-free, phosphate-buffered saline solution 
(Puck’s saline) at 4°C. Routinely, 12-20 ganglia were removed from 
each embryo’ and 12-l 8 embryos were dissected at one time. After 
dissection, the ganglia were transferred to a sterile 15 ml centrifuge tube, 
washed with Puck’s saline. and then incubated at 37°C for 30 min in 
Puck’s saline containing 0.6 1% crude collagenase. The ganglia were then 
gently pelleted by centrifugation at 500 x g for 5 min, the supematant 
discarded, and the ganglia resuspended in growth medium. The growth 
medium was Dulbecco’s Modified Eagle’s Medium supplemented with 
2 mM glutamine, 50 U/ml penicillin, 50 j&ml streptomycin, 10% (v/ 
v) heat-inactivated fetal calf serum, 5% (v/v) chicken embryo extract 
(Dichter and Fischbach, 1977), and 100 or 200 @ml of 7s nerve growth 
factor (Collaborative Research Inc., Lexington, MA). Individual cells 
were dissociated from the ganglia by trituration using a fire-polished 
Pasteur pipette until a cloudy suspension was observed. The cells were 
counted using a hemocytometer and diluted in growth medium, and 
approximately 300,000-400,000 cells were plated on 60 mm collagcn- 
coated Falcon brand culture dishes. For electrophysiological experi- 
ments, small plastic coverslips were placed on the bottom of the culture 
dishes. They were collagen coated, and cells were plated directly onto 
these slips. The cells are grown for 3 d at 37°C in a 5% CO, atmosphere, 
using growth medium containing either IO PM cystosine P-D-arabino- 
furanoside, or 50 PM 5-fluoro-2’-deoxyuridine and 150 PM uridine to 
minimize growth of non-neuronal cells. After 3 d ofexposure to mitotic 
inhibitors and every other day thereafter, neurons were fed with 2 ml 
of medium without mitotic inhibitors. Using this protocol, neuronal 
cultures make extensive neurite processes by the third day in culture, 
with most non-neuronal cells dying and no longer adhering to the culture 
dish. Typically by day 6 in culture, approximately 90% of the viable 
cells are neurons. 
Substance P release. After 5-7 d of growth, release studies were per- 
formed using a modification of the method of Mudge et al. (1979). 
Medium was gently aspirated from the culture dish, and the cells were 
washed with I ml of a modified Krebs’ bicarbonate buffer consisting of 
135 mM NaCI, 3.5 mM KC], I mM MgCI,, 20 mM NaHCO,, 2.5 mM 
CaCI,, 3.3 mM dextrose, 100 FM ascorbic acid, 20 PM bacitracin, and 
0.5% bovine serum albumin, aerated with 95% 0,. 5% CO,, pH 7.4- 
7.5, and maintained at 36-37°C. Cells were then incubated for two 
consecutive 5 min periods with I ml of Krebs’ buffer to measure resting 
release (referred to in the text as basal release), followed by one 5 min 
exposure to Krebs’ buffer containing either 40 mM or 50 mM KCI (sub- 
stituted for equimolar sodium), PGE,, PGF,, arachidonic acid, or LTB,. 
Cells were then reexposed for two 5 min incubations with Krebs’ buffer 
containing 3.5 mM KCI to reestablish basal release. For all experiments, 
eicosanoids were initially dissolved in 70% ethanol or in I-methyl-2- 
ovrrolidinone (Aldrich Chemical Co.. Milwaukee, WI) and diluted to 
appropriate concentrations with Krebs’ buffer. During each 5 min in- 
cubation, cells were rctumed to the incubator. After each 5 min incu- 
bation, the Krebs’ buffer was carefully aspirated and pipetted into 12 
x 75 mm culture tubes containing glacial acetic acid such that the final 
and reconstituted in an assay buffer of 0. I M phosphate buffer (pH 7.4- 
7.5) containing 0.9% NaCl, 0. I% gelatin, and 2 ppm phenol red. Five 
to nine microliters of 2 N NaOH were added to each sample to adjust 
the pH to approximately 7. Neutralized solutions were centrifuged and 
supematant was assayed for SP as described below. In all experiments, 
release by a test substance was compared to basal release and results 
were expressed as total picograms of SP released. 
Measurement ofsubstance P content in DRG neurons. Following the 
release protocol, the content of SP in these neurons was determined in 
each culture dish. One milliliter of 2 N acetic acid was added to each 
dish containing DRG neurons and incubated at room temperature for 
15 min. The solution was then removed and the procedure repeated a 
second time. The extracts were combined and diluted 1:20, 1:50, and 
1:lOO with 2 N acetic acid. Samples were frozen, lyophilized, and as- 
sayed for SP as described below. 
Radioimmunoassay for substance P. Substance P was assayed using 
a modification of our previously described radioimmunoassay (Pang 
and Vasko, 1986). Briefly, the radioimmunoassay was performed by 
adding 25 PI of the I:8000 dilution of the anti-substance P serum (57P) 
and 25 ~1 of 12’I-8-Tyr-SP containing 4000-5000 cpm to 300 ~1 of 0. I 
M phosphate buffer containing known amounts of SP (ranging from 2.5 
to 500 pg) or to 300 ~1 of the reconstituted unknown samples. This 
mixture was then incubated for 16-18 hr at 4°C. After incubation, 500 
~1 of a charcoal solution consisting of 1% Norite I charcoal suspended 
in 0. I M phosphate buffer (pH 7.5) containing 0.3% NaCI, and 0. I% 
bovine serum albumin were added to each tube. This solution was 
centrifuged at 1500 x g for 15 min at 4°C to remove unbound peptides. 
The supematant was decanted and the radioactivity determined by 
gamma scintillation spectrometry. The amounts ofSP in unknown sam- 
ples were estimated by comparing unknown samples to the “logit-log” 
linearized standard curve (Rodbard and Leward, 1970). Using this 
method, the minimal detectable limit (95% confidence interval) was 5 
pg of SP with a 50% displacement of bound peptide at approximately 
75 Pg. 
With each chemical manipulation, standard curves for SP were de- 
termined in the presence of the highest concentration of test compound 
to confirm that the experimental manipulation did not alter the standard 
curve. Anti-substance P serum was raised in our laboratory from rabbits 
using thyroglobulin-bound SP (Pang and Vasko, 1986). The antibody 
used does not cross-react to any significant degree with a number of 
other peptides including the tachykinins: neurokinin A, neurokinin B, 
kassinin, eledoisin, or physalacmin; nor does it cross-react with ara- 
chidonic acid metabolites. 
Chromatography. Neurons were exposed to I ml of Krebs’ bicarbon- 
ate buffer containing 50 mM KCI for 5 min to release SP. This solution 
was then acidified using acetic acid such that the final concentration 
was 2 N. frozen, and lyophilized. After lyophilization, the sample was 
resuspended in mobile phase consisting of 0.2 ml of 69Oh H,O, 30% 
acetonitrile, and I % phosphoric acid (v/v), and the sample was injected 
onto an 8 mm i.d. 4 PM Cl 8 radial Pak L.C. cartridge (Waters Associates, 
Milford, MA) that was preequilibrated with mobile phase. Peptide was 
eluted with the mobile phase at a flow rate of I ml/min. Fractions were 
collected at 30 XC intervals, the organic phase evaporated under a 
nitrogen stream, and the aqueous phase frozen. Frozen samples were 
lyophilized, resuspended in assay buffer (see above), and assayed for SP 
as described above. A parallel run was performed with the SP standard. 
Measuremenl of calcium currents. Avian DRG neurons were plated 
and cultured on small plastic coverslips as described above. After a 
period of 5-7 d, a coverslip was removed from the culture dish and 
transferred to the bottom of a small recording chamber. In order to 
eliminate sodium and potassium currents, the neurons were bathed in 
a solution ofthe followingcomposition (in mM): 105 CsCI, 20 tetraethyl- 
ammonium chloride, IO BaCI,, I MgCl,, 10 HEPES, 10 glucose, and 1 
PM tctrodotoxin (pH adjusted to 7.4 with either free base arginine or 
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Figure 1. Potassium-stimulated release of SP from avian DRG neurons is dependent on extracellular calcium. The ordinate represents the amount 
of SP released/dish of neurons/5 min incubation. Each column represents the mean f  SEM of the resting or basal release (Basal, open columns) 
or the release in the presence of 50 mM KC1 (Slim, hafched columns). A is the release in buffer containing 2.5 mM calcium, whereas B represents 
the release in buffer containing no added calcium and 2 mM EGTA. The number of dishes examined is indicated in each panel. The asterisk 
indicates statistically significant differences (p < 0.05) from the basal release. 
CsOH). The recording chamber was then placed on the stage of an 
inverted microscope for viewing the cells and placement ofthc recording 
electrode. The recording chamber had an approximate volume of 500 
~1 and was superfused by a gravity flow/aspiration setup. 
The calcium current (Ic.) was recorded from chick DRG neurons by 
utilizing the whole-cell patch-clamp technique (Hamill et al., I98 I). 
Membrane currents were recorded with a EPC-7 patch-clamp amplifier 
(List Electronic, Darmstadt, Germany). The recording pipettes were 
pulled from borosilicate disposable pipettes and were filled with the 
following solution (in mM): 50 CsCI, 50 N-methyl-D-glucamine chloride, 
IO tetraethylammonium chloride, 2 MgCI,, IO EGTA, IO HEPES, and 
4 Na,-ATP (pH adjusted to 7.2 with free base arginine or CsOH). The 
pipette solution had an osmolality of about 275 mOsm. These pipettes 
typically had resistances of 2-4 MQ. 
The recording pipette was placed against the surface of the DRG 
neuron, and gentle suction was applied by mouth until a sealing resis- 
tance of 2-10 CR was obtained. Additional suction was then applied to 
the pipette until there was a large increase in the pipette capacitance, 
indicating attainment of the whole-cell configuration. The cell capaci- 
tance was compensated nominally by approximately 70% and had typ- 
ical series resistance values of 3-5 MR. The whole-cell current recordings 
were sampled at 0.5 msec per point. The cells were held at resting 
potentials of either -60 or -90 mV. Depolarizing voltage steps of IO 
mV and 175 msec in duration were computer generated with the soft- 
ware package of pcuhfp (Axon Instruments, Inc., Foster City, CA). 
Data storage and analysis were accomplished with the ~CLAMP package. 
In all the current traces shown, the capacitive and linear leakage currents 
have been subtracted by averaging and scaling four hyperpolarizing steps 
one-fourth the amplitude of the test potential. All experiments were 
done at room temperature (22-25°C). 
Statistics. All release data are presented as the mean f  SEM for four 
to nine dishes of neurons. To compare basal and stimulated SP release, 
analysis of variance and Bonferroni’s procedure for multiple t tests were 
performed on basal versus stimulated release (Wallenstein et al., 1980). 
Because the first period of basal release was not significantly different 
from the second period of basal release in any of the experiments, 
statistical comparisons were made between the initial basal release and 
the stimulated release. Student’s f test was used to compare potassium- 
evoked release with release evoked by test substance. Significance level 
for each test was set at 0.05. Evoked release is defined as the amount 
of SP released during the 5 min of stimulation minus the average of the 
basal releases prior to stimulation. 
Results 
Characterization of substance P release 
Experiments were first performed to characterize potassium- 
stimulated release of SP. As can be seen in Figure 1 A, exposure 
of DRG neurons to Krebs’ buffer containing 3.5 mM KC1 results 
in a resting or basal release of 30 + 6 and 24 -t 6 pg/dish of 
cells/5 min for the first two incubation periods, respectively. 
When the extracellular concentration of KC1 is increased to 50 
mM, the release ofSP is increased approximately four- to fivefold 
to 138.4 -t 15 pg/dish/5 min (Fig. 1A). The potassium-stimu- 
lated release does not occur when neurons are incubated with 
Krebs’ buffer containing no added calcium and 2 mM EGTA 
(Fig. lB), suggesting that the evoked release of SP is calcium 
dependent. Basal release of SP is not altered by the extracellular 
calcium concentration. The total content of SP in each dish of 
cells ranged from 2 to 4 ng, with basal release being approxi- 
mately 1% of total content, whcrcas potassium-stimulated re- 
lease is approximately 4% of total SP content. 
To ascertain if the immunoreactive product released from 
DRG neurons is SP, we determined whether it cochromato- 
graphs with authentic SP using reverse-phase HPLC. As shown 
in Figure 2, the majority of the SP-like immunoreactivity that 
is released from neurons exposed to Krebs’ bicarbonate buffer 
cochromatographs with authentic SP. 
Eflect of PGE, on substance P release 
Because PGE, produces hyperalgesia and lowers the threshold 
of activation in sensory neurons, it seems likely that the eicosa- 
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Figure 2. The immunoreactive product released by potassium stim- 
ulation of avian DRG neurons coelutes with authentic SP. Samples were 
chromatographed using HPLC as discussed in the Materials and Meth- 
ods. The ordinate represents the SP-like immunoreactivity in pg/frac- 
tion measured by the radioimmunoassay. The abscissa represents the 
fractions collected every 0.5 min. 
noid could increase the release of neurotransmitter from these 
neurons. Consequently, we studied whether PGE, could stim- 
ulate the release of SP from sensory neurons grown in culture. 
The release protocol was performed on dishes of neurons where 
the cells were exposed during the third incubation period to 
either Krebs’ buffer containing 40 mM KC1 or buffer containing 
various concentrations of PGE, (3.5 mM KCl). Results of these 
studies are illustrated in Figure 3. Exposure of cells to PGE, 
produces a dose-dependent increase in the release of SP above 
basal release. PGE, at a concentration of 1 PM stimulates the 
release of SP approximately twofold over basal release, whereas 
both 5 and 10 PM PGE, increases the release approximately 
fourfold. The evoked release, that is, stimulated release minus 
basal release, caused by 1 PM PGE, is 23 f 8 pg/dish/5 min, 
by 5 FM PGE, is 66 * 7 pg/dish/5 min, and by 10 PM PGE, is 
63 -t 3 pg/dish/5 min. Evoked release produced by 40 mM KC1 
is 45 + 3 pg/dish/5 min (Fig. 3) whereas the release caused by 
50 mM KC1 is .113 + 10 pg/dish/5 min (see Fig. 1). For neurons 
exposed to either 1 I.LM or 5 I.LM PGE,, the release of SP returns 
to the basal level when the buffer is replaced with Krebs’ buffer 
lacking PGE,. In contrast, release of SP after exposure to 10 FM 
PGE, remains elevated even after the eicosanoid is removed. 
Efects of PGE, on calcium currents 
The PGE,-induced increase in SP release observed in DRG 
neurons may be due to an increase in the influx of calcium since 
the release of neurotransmitter is usually dependent on calcium 
influx. Consequently, we determined whether PGE, could fa- 
cilitate the inward calcium current in these neurons. The ad- 
dition of PGE, produced a significant increase in the amplitude 
of I,, as recorded in these neurons by utilizing the whole-cell 
patch-clamp technique. These results are illustrated in Figure 
4. Under control conditions, an inward current whose maximum 
amplitude of -412 pA is obtained at 0 mV (Fig. 4A,C). When 
the perfusate is changed to one containing 1 PM PGE,, there is 
a large and rapid increase in Z,, recorded with this voltage pro- 
tocol (Fig. 4B,C). The maximum value of Zca under these con- 
ditions is increased to -854 pA. As in the control recording, 
the maximal value is obtained at 0 mV, indicating no significant 
change in the activation profile for this inward I,,. The PGE,- 
induced increase in I,, is observed after 2 min of exposure to 
the eicosanoid. However, the increase in Zc, was not sustained 
and returned to normal levels within 10 min of exposure to the 
PG (data not shown). The amplitude of I,, and its dependence 
on the applied voltage are presented in the current-voltage re- 
lation shown in Figure 4C. The current-voltage curves for this 
DRG neuron demonstrate that the addition of PGE, enhances 
I,, at all voltage steps except where the driving forces are likely 
to be small (-+60 and k50 mV). The maximum value of I,, is 
obtained at 0 mV and undergoes a twofold elevation in the 
presence of PGE,. 
The capacity of PGE, to enhance I,, was observed in seven 
of nine DRG neurons studied, and these results are summarized 
in the current-voltage relations illustrated in Figure 5, A and B. 
The data are normalized to the peak values of I,, under the 
control conditions. For a holding potential of -60 mV (Fig. 
5A), the mean peak value of I,, (n = 4) for each voltage step 
was normalized to -376 pA at + 10 mV. In neurons exposed 
to PGEI, the mean I,, value is enhanced about 1.8-fold (Fig. 
5A). In a similar manner, when the holding potential was -90 
mV (Fig. SB), the peak value of I,, (n = 3) is increased by about 
1.4-fold upon the addition of PGE,. For both holding potentials, 
the PGE,-induced elevation in I,, was not observed for voltage 
steps below -20 mV. The lack of any significant increase in I,, 
for voltage steps below -20 mV (especially at the holding po- 
tential of -90 mV) suggests that PGE, is affecting primarily 
L-type calcium channels rather than the T-type calcium chan- 
nels (Fox et al., 1987). For a holding potential of -60 mV, 
exposure to PGE, appears to shift the voltage at which the peak 
value of I,, is obtained. For the control current-voltage curve, 
the peak I,, occurred at + 10 mV, whereas the peak value of I,, 
in the presence of PGE, occurred at 0 mV. This 10 mV shift 
may not be significant and may reflect the variability of Z,, for 
the small sample size. This shift was not observed for the -90 
mV holding potential. These results demonstrate that PGE, can 
enhance the activation of I,-, in DRG neurons grown in culture. 
Effects of arachidonic acid 
To determine if the effects of PGE, are selective and not the 
result of formation of other metabolic products of arachidonic 
acid, we studied whether the metabolic precursor of PGE,, ar- 
achidonic acid, could alter the release of SP or calcium currents 
in DRG neurons. Release experiments were performed using 
different groups of cells with or without indomethacin pretreat- 
ment. The results from these experiments are shown in Figure 
6. When neurons are exposed to 10 PM arachidonic acid, there 
is no significant increase in the release of SP (Fig. 6B). Basal 
release for the 5 min period prior to exposure to arachidonic 
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acid is 26 + 4 pg/dish/5 min, whereas the release in the presence 
ofarachidonic acid is 3 1 f 4 pg/dish/5 min. In neuronal cultures 
prepared from the same DRG cell harvests, a significant increase 
in release of SP from 34 + 3 pg/dish/5 min to 129 + 14 pg/ 
dish/5 min is observed after exposure to 50 mM KC1 (Fig. 6A), 
demonstrating that the absence of any arachidonic acid effect is 
not due to a lack of neuronal viability. Basal release of SP from 
neurons exposed to arachidonic acid for 5 min does not return 
to the levels observed prior to arachidonic acid, but increases 
to 44 + 4 and 48 f. 2 pg/dish/5 mitt, which is significantly 
higher than the initial basal release. However, this late increase 
in SP release is not observed when cells are pretreated with 10 
&ml indomethacin for 30 min (Fig. 6C). Basal release for the 
5 min period prior to exposure to arachidonic acid is 14 -+ 1 
pg/dish/5 min. Exposure to 10 PM arachidonic acid does not 
alter the release and has a value of 15 f 2 pg/dish/5 min. After 
arachidonic acid is removed, the release remains similar to that 
observed for the control condition, having values of 11 f 1 and 
10 + 2 pg/dish/5 min. Potassium-stimulated release is not al- 
tered by indomethacin pretreatment (data not shown). These 
results suggest that this late rise in SP release observed after 
exposure to 10 .+.LM arachidonic acid may result from the for- 
mation of a product of the metabolism of arachidonic acid by 
cyclooxygenase. 
We also examined the effects of arachidonic acid on calcium 
currents in DRG neurons. The addition of either 1 PM or 10 
PM arachidonic acid does not cause any significant increase in 
I,. In experiments utilizing the larger concentration of arachi- 
donic acid, the peak value for the amplitude of I, under the 
control condition is - 1313 + 293 pA (mean + SEM; n = 7; 
Figure 3. Various concentrations of 
PGE, stimulate the release of SP from 
avian DRG neurons. The ordinates rep- 
resent the amount of SP released/dish 
of neurons/5 min incubation. Each col- 
umn represents the mean k SEM of the 
release of SP for each 5 min incubation. 
In each case, the data are presented 
showing the basal release during a 5 min 
exposure to Krebs’ buffer containing 3.5 
mM KC1 (Basal, open cohnns), or re- 
lease from neurons exposed for 5 min 
to buffer containing 40 mM KCl, or for 
5 min to Krebs’ buffer containing 3.5 
mM KC1 and various concentrations of 
PGE, as indicated (Mm, hatched col- 
umns). The number of dishes examined 
is indicated in each panel. The asterisk 
indicates statistically significant differ- 
ences from basal release. 
range, -322 to -2637 PA) whereas 2-5 min after the addition 
of 10 KM arachidonic acid the peak value of I,-, is - 1360 + 348 
pA (mean f SEM; n = 7; range, - 32 1 to - 276 1 PA). For both 
the control and 10 PM arachidonic acid conditions, the peak 
value of I,, for each voltage step was normalized to the maximal 
value of I,, under its respective control condition. The nor- 
malized values were then averaged, these results are illustrated 
in Figure 7. The current-voltage curves for both the control and 
arachidonic acid are very similar. The peak values of I,, for 
both the control and arachidonic acid conditions occur at 0 mV. 
Arachidonic acid also does not have any significant effect on I, 
over the long term. In two of the seven neurons where I,, was 
examined at 10 and 20 min after the addition of 10 PM ara- 
chidonic acid, the peak value of I,, under the control condition 
is - 1020 pA (mean of two neurons) whereas 10 and 20 min 
after the addition of arachidonic acid, I, is -972 and -936 
pA, respectively. 
Similar results occur when neurons are exposed to 1 PM ar- 
achidonic acid. The peak value for the amplitude of I,, under 
the control condition is - 674 + 113 pA (mean + SEM; n = 9; 
range, - 196 to - 1297 PA), whereas 10 min after the addition 
of 1 PM arachidonic acid the peak value of I,-., is -693 + 133 
pA (mean f SEM; n F 9; range, - 196 to - 1308 PA). These 
results indicate that arachidonic acid has no direct action on 
the amplitude or voltage dependence of I,, in these sensory 
neurons. 
Efects of PGF,, and LTB, 
There is evidence that both PGF,, and LTB, also produce hy- 
peralgesia, although this action does not appear to be the result 
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Figure 4. PGE, enhances the calcium current in a single avian DRG neuron. For A and B, the ordinate represents the membrane current in pA, 
whereas the abscissa is the time in milliseconds. The cell was held at -60 mV, incremental voltage steps of 10 mV were then applied until the 
maximal value of +60 mV was reached. The timing and duration of the voltage step are shown in the bottom truce. A represents recording of Ic. 
from a DRG neuron in whole-cell mode under control conditions. B shows Ic, in the same cell 2 min after the addition of 1 PM PGE, to an identical 
series of voltage steps. This allows sufficient time for the bath volume to be turned over four times. C represents the dependence of 1, on the 
applied voltage step for both the control condition (open circles) and after addition of PGE, (solid triangles). 
of a direct effect on sensory neurons (Levine et al., 1984; Taiwo 
and Levine, 1986). Based on this finding, and to determine 
further the specificity of the effects of PGE,, we also examined 
the effects of PGF,, and LTB, on DRG neurons grown in culture. 
Release studies were performed as described above. Dishes of 
neurons were exposed to either Krebs’ buffer containing 3.5 mM 
KCl, buffer containing 50 mM KCl, or buffer containing 3.5 mM 
KC1 and 10 PM PGF,, or 1 PM LTB,. The results of these ex- 
periments are illustrated in Figure 8. As previously observed, 
exposure of neurons to 50 mM KC1 results in an approximate 
fivefold increase in the release of SP from a basal release of 20 
L 5 pg/dish/5 min to 102 + 6 pg/dish/5 min (Fig. 8A). The 
addition of 10 pM PGF,, to the Krebs’ buffer (KC1 concentration 
of 3.5 mM) has no significant effect on the release of SP. Basal 
release in these neurons is 23 t 3 and 19 k 3 pg/dish/5 min 
compared to a release of 24 f 1 pg/dish/5 min in the presence 
of PGF,, (Fig. 8B). In a similar manner, exposure of neurons 
to 1 PM LTB, does not significantly alter release above the basal 
levels. Basal release in these neurons is 23 f 4 pg/dish/5 min, 
whereas the release in the presence of LTB, is 28 +- 4 p&dish/5 
min (Fig. SC’). 
The addition of PGF,, to the medium bathing the DRG neu- 
rons did not alter the amplitude of I,,. In the control condition, 
I,, has a maximum value of - 1179 k 126 pA (mean f SEM; 
n = 12; range, -436 to -2063 PA), whereas after a 2 min 
exposure to 10 PM PGF,,, Z, has a maximum value of - 1259 
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Figure 5. Normalized current-voltage relationships for control and PGE,-treated DRG neurons. The values of Zc, obtained for each voltage step 
were normalized to their respective maximal value of Ze. under control conditions. The values of Zc, obtained after the addition of 1 ELM PGE, 
(range, 1 S-6 min) were then normalized to their respective peak values for the control Z&. The ordinate represents the normalized current values, 
and the abscissa, the applied voltage step. A and B represent neurons with holding potentials of -60 mV (n = 4) and -90 mV (n = 3), respectively. 
Open circles represent Ze. from control cells, and solid triangles represent neurons treated with 1 PM PGE,. 
f 143 pA (mean f SEM; n = 12; range, -480 to -2019 PA). 
For both the control and PGF,, conditions, the peak value of 
I,, for each voltage step was normalized to the maximum value 
of Z,, under its respective control condition. The normalized 
values were then averaged; these results are shown in Figure 9. 
The presence of PGF,, has no significant effect on the amplitude 
of I,, recorded at all voltage steps. 
LTB, also does not significantly alter I,,. The addition of 1 
PM LTB, has only a slight effect on I,,. In recordings from two 
DRG neurons, the peak values of I,, are - 13 13 and - 1896 pA 
for a holding potential of -90 mV under control conditions 
(data not shown). In recordings from nine other neurons held 
at -90 mV, the peak values of I,, ranged from -800 to -2500 
PA. After 15 min of exposure to 1 I.LM LTB,, the peak value of 
I,-= had increased about 1.1 -fold to - 1530 and - 2067 pA, re- 
50 mM KCI 
A 
140 ( n=6 
120. 
100. 
60. 
60. 
40 
20 
0 Kl -iEr 
spectively, for the two neurons. No effect is observed after 1 
min. This slight stimulatory action of LTB, may reflect a phys- 
iological role for the lipoxygenase product of arachidonic acid, 
although there is little effect compared to the action of PGE,. 
More likely, it is a nonspecific effect. The lack of a significant 
action of LTB, within minutes of its administration and the lack 
of effect of either PGF,, or arachidonic acid are consistent with 
the notion that the in situ metabolic products of either the cy- 
clooxygenase or lipoxygenase pathways are not responsible for 
the enhanced Zca observed upon the application of PGE,. 
Discussion 
In initial experiments, we characterized the release of SP from 
avian DRG neurons grown in culture. In a majority of the dishes 
of cells used, the neurons contained approximately 2-4 ng of 
10pM Arachidonic Acid 
B 
I 
n=6 
Basal Basal Stim Basal Basal 
10 MM Arachidonic Acid 
C lndomethacin Pretreatment 
I 
n=6 
: QIxzizmn~ 
Basal Basal Stim Basal Basal 
Figure 6. Arachidonic acid does not alter the release of SP from DRG neurons. The ordinates represent the amount of SP released/dish of 
neurons/5 min incubation. Each column is the mean * SEM for cells exposed to Krebs’ buffer containing either the control or the experimental 
solutions. A represents the control experiments with neurons exposed to buffers containing either 3.5 mM KC1 (Basal, open columns) or 50 mM 
KC1 (Stim, hatched column). B illustrates the release from neurons exposed to Krebs’ buffer containing either 3.5 mM KC1 (Basal, open columns) 
or 3.5 rnM KC1 and 10 PM arachidonic acid (Stim, hatched column). C represents the release from cells pretreated with indomethacin (10 &ml) 
for 30 min and then exposed to 10 PM arachidonic acid; open and hatched columns are the same as in B. The number of dishes examined is 
indicated in each panel. The asterisk indicates statistically significant differences from the basal release prior to arachidonic acid exposure. 
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Figure 7. Arachidonic acid has no effect on calcium currents in DRG 
neurons. The points in the current-voltage relation represent the nor- 
malized mean values of I,, for both the control condition (open circles) 
and after the addition of 10 PM arachidonic acid (solid triangles) for 
seven DRG neurons. The peak values of Zc, for each voltage step under 
control and arachidonic acid conditions were normalized to the max- 
imum value of Zc, obtained under the control condition for each re- 
spective neuron. These normalized values were then averaged and are 
shown in the current-voltage relation above. The experimental record- 
ings were obtained between 2 and 5 min after the addition of arachidonic 
acid. The holding potential was -60 mV. 
SP per dish of cells. This is similar to the total tissue content 
reported by Mudge et al. (1979) for avian DRG neurons grown 
in cell culture. In addition, both the basal (resting) and potas- 
sium-stimulated release of SP observed in these experiments 
are similar in magnitude to values reported by Mudge et al. 
(1979) and Holz et al. (1988). Basal SP release is approximately 
1% of the total tissue content of the peptide, whereas the release 
evoked by 50 mM KC1 represents approximately 4% of the total 
content. This potassium-stimulated release is dependent on ex- 
MEMBRANE POTENTIAL (mV) 
NORMALIZED 
CURRENT 
Figure 9. PGF,, does not significantly alter the calcium current in DRG 
neurons. The points in this current-voltage relation represent the nor- 
malized mean values of Zc, for both the control condition (open circles) 
and after the addition of 10 PM PGF,, (solid triangles) for 12 DRG 
neurons. The peak values of Zc, for each voltage step under control and 
PGF,, conditions were normalized to the maximum value of Zc. ob- 
tained under the control condition for each respective neuron. These 
normalized values were then averaged and are shown in the current- 
voltage relation above. The experimental recordings were obtained 2 
min after the addition of PGF,,. The holding potential was -60 mV. 
tracellular calcium. These results are comparable to release of 
SP from other neuronal preparations (Jesse11 and Iversen, 1977; 
Gamse et al., 1981; Pang and Vasko, 1986) and suggest that 
sensory neurons in culture are a valid model for studying trans- 
mitter release. The immunoreactive substance released by the 
cells and measured using our radioimmunoassay appears to be 
authentic SP because its elution profile on HPLC is similar to 
that of the SP standard and because the antisera we use in the 
assay does not cross-react to any significant degree with any 
known mammalian tachykinin. 
A 
60 mM KCI 
B 
10 pM PGF 2a C 
1 pM LTB4 
.; 140 1 n=7 T 
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Figure 8. The eicosanoids, PGF,, and LTB, do not alter SP release from DRG neurons. The ordinates represent the amount of SP released/dish 
of neurons/5 min incubation. Each column is the mean * SEM for cells exposed to Krebs’ buffer containing either the control or the experimental 
solutions. A represents control experiments for neurons exposed to Krebs’ buffer containing either 3.5 mM KC1 (Basal, open columns) or 50 mM 
KC1 (Stim, hatched column) to evoke release. B illustrates the release obtained for neurons exposed to either the control conditions of 3.5 mM KC1 
(Basal, open columns) or 3.5 mM KC1 and 10 PM PGF,, (Stim, hatched column). C illustrates the release from neurons exposed to either 3.5 rnM 
KC1 (Basal, open columns) or 3.5 mM KC1 and 1 PM LTB, (Stim, hatched column). The number of dishes examined is indicated in each panel. 
The asterisk indicates statistically significant differences from the basal release. 
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Extensive experimental evidence suggests that PGE, is a direct 
chemical mediator involved in sensitizing sensory neurons; con- 
sequently, we sought to determine if this cicosanoid could en- 
hance neurotransmittcr release from sensory neurons. We chose 
to study the release of SP from DRG cells because abundant 
evidence suggests that this peptide is an important neuroactive 
compound in nociceptive sensory neurons (see reviews by Salt 
and Hill, 1983; Cuello, 1987). In addition, SP appears to be an 
important mediator of components of the inflammatory re- 
sponse, especially neurogenic inflammation (Payan, 1989). Our 
results demonstrate that PGE, stimulates the release of SP from 
avian DRG neurons in a dose-dependent manner. Exposure of 
neurons to 1 PM PGE, results in a small but significant increase 
in SP, whereas at higher concentrations the evoked release is 
similar to that observed with elevated concentrations of extra- 
cellular potassium. The concentrations of PGE, utilized in the 
current studies are similar to those required to sensitize sensory 
neurons to noxious stimuli as observed in previous reports. For 
example, Yanagisawa et al. (1986) demonstrated that 0.84 PM 
PGE, enhanced the nociceptive reflex in an isolated spinal cord- 
tail preparation from newborn rat. A lesser concentration of 
PGE, (0.1 PM) potentiated the potassium-induced firing of rat 
sensory neurons grown in culture (Baccaglini and Hogan, 1983). 
In addition, micromolar concentrations of PGE, are required 
to increase the influx of calcium in neuroblastoma-glioma hy- 
brid cells (Miwa et al., 1988) and to stimulate catecholamine 
release from bovine adrenal chromaffin cells (Koyama et al., 
1988). 
The PGE,-induced increase in SP release is relatively selective 
for this prostanoid because neither PGF,,, arachidonic acid, nor 
the lipoxygenase metabolic product LTB, significantly enhances 
SP release upon acute exposure. Neurons exposed to 10 PM 
arachidonic acid for 5 min show a slight but significant increase 
in SP release during the two 5 min collections following removal 
of arachidonic acid, an effect that is attenuated by the indo- 
methacin pretreatment. This latter effect suggests that arachi- 
donic acid is being metabolized to a PG by the cells in culture. 
In fact, Vesin and Droz (199 1) have demonstrated that after a 
10 min incubation period with labeled arachidonic acid, avian 
DRG neurons grown in culture can metabolize arachidonic acid 
to various PGs, especially PGE,. Of primary importance, how- 
ever, is our result demonstrating that arachidonic acid does not 
have an immediate action (at least within 10 min), supporting 
the idea that the enhanced release of SP is specific for PGE,. 
The results presented in this study demonstrate that PGE, 
can increase the amplitude of I,, elicited by voltage steps in 
these sensory neurons. As with the release studies, the effect of 
PGE, on I,, appears to be relatively specific since neither PGF,,, 
arachidonic acid, nor the lipoxygenase product LTB, enhances 
I,, in an analogous manner. The voltage dependence for acti- 
vation of I,. does not appear to be affected by PGE, since the 
maximal value of I,, is obtained at the same voltage step for 
both the control and experimental conditions. This enhance- 
ment of Ica occurred with a rapid onset, reaching maximal levels 
within 2 min, but appeared to be a transient phenomenon since 
the peak value of I,, had returned to nearly the control value 
after about 10 min in the PGE, solution. A similar time course 
has been reported for PGE,-induced I, activation in bovine 
chromaffin cells (Mochizuki-Oda et al., 199 I). This result sug- 
gests that the neuron has somehow desensitized to the activating 
effects of PGE, and implies either that the transduction cascade 
has decreased its sensitivity to PGE, or that PGE,-sensitive 
calcium channels have inactivated. One obvious limitation of 
the current results is that only one concentration of PGE, was 
examined. We chose to use 1 PM PGE, based on the rclcase 
studies showing that this was the lowest concentration tested 
that evoked release. Because this low concentration was effective 
in enhancing I,,, higher concentrations were not examined. 
In both chick and rat DRG neurons, the release of SP is 
believed to be mediated by L-type calcium channels. The po- 
tassium-stimulated release of SP from these neurons can be 
blocked with the addition of dihydropyridine calcium channel 
antagonists such as nitrendipine and nifedipine (Pemey et al., 
1986; Rane et al., 1987). Thus, our findings that PGE, can 
increase both the release of SP and I,-, in chick DRG neurons 
is consistent with the notion that PGE, may be modulating the 
activity of L-type calcium channels. This is based on the fact 
that the capacity of PGE, to enhance I,, was similar for holding 
potentials of either -60 or -90 mV (see Fig. 54,B) and this 
enhancement occurred only for voltage steps that were greater 
than -20 mV (see Figs. 4C, 5A). Also, the inactivation of I,., 
was relatively slow and lacked the rapid transient relaxation 
(data not shown) indicative of N-type channel activity (Fox et 
al., 1987). 
It seems likely that the enhancement of I,, by PGE, may 
contribute to the increase in SP release produced by this eicosa- 
noid. However, !his was not specifically determined in our ex- 
periments, because not all the neurons grown in cell culture 
synthesize and release SP. Therefore, it is possible that the ob- 
served changes in I,, are recorded from neurons other than those 
containing SP. An analogous mechanism for the enhancement 
of transmitter release by activation of I,, has been observed in 
bovine chromaffin cells and may be particularly relevant to these 
nociceptive sensory neurons. Addition ofdopamine to the chro- 
maffin cell stimulates a specific set of calcium channels whose 
activity appears to be controlled by CAMP and CAMP-depen- 
dent protein kinase (Artalejo et al., 1990). This facilitation of 
I,-, may contribute to the release of more neurotransmitter, that 
is, a positive feedback mechanism to boost epinephrine levels 
beyond those normally released. In sensory neurons, PGE, may 
act through a similar type of pathway where PGE, acts to en- 
hance Ica and thus facilitate the release of SP. 
The mechanism of action for the increase in transmitter re- 
lease and the activation of calcium channels remains unknown. 
It is possible that PGE, activates calcium channels directly, 
although to our knowlcdgc, there is no evidence available to 
support this possibility. However, PGs are known to modulate 
the activity of many different types of second messenger systems 
(see reviews by Halushka et al., 1989; Shimizu and Wolfe, 1990). 
PGs alter intracellular CAMP content in superior cervical ganglia 
(Tomasi et al., 1977) neuroblastoma-glioma cells (Sharma et 
al., 1975) and bovine adrenal medulla (Negishi et al., 1989). 
In addition, in animal models of pain, the enhanced sensitivity 
to noxious stimuli produced by PGE, may be mediated by CAMP 
(Ferreira and Nakamura, 1979; Taiwo et al., 1989). In bovine 
chromaffin cells, the addition of PGE, increases the influx of 
calcium into the cell through potentiation ofthe calcium current. 
Presumably, this effect is mediated via PG stimulation of the 
inositol trisphosphate (IP,) pathway wherein IP, presumably 
activates the calcium channels directly (Mochizuki-Oda et al., 
199 1). These results in bovine chromaffin cells are, at this point, 
speculative because the calcium currents activated by PGE, have 
not been shown to be the same population of currents activated 
by IP,. Further studies are warranted to determine whether 
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PGE, activates or recruits additional calcium channels such as 
is the case for facilitation-type calcium channels (Artalejo et al., 
1990) or whether PGE, shifts the probability toward the open 
state for active calcium channels through modulating the activ- 
ity of a second messenger system. 
It is interesting to speculate that the increase in neurotrans- 
mitter release and activation of voltage-sensitive calcium chan- 
nels may be one mechanism to explain the sensitizing action of 
PGE, on sensory neurons. It is largely accepted that PGs are 
synthesized and released in response to tissue injury, contribute 
to hyperalgesia, and are involved with the acute inflammatory 
response (Ferreira, 1983; Higgs and Moncada, 1983; Payan, 
1989). The hyperalgesic effect of PGE, appears to result from a 
direct action on sensory neurons because the onset of effect is 
rapid (Taiwo et al., 1987) and because neither indomethacin 
pretreatment, polymorphonuclear leukocyte depletion, nor le- 
sion of sympathetic nerves alters PGE,-induced hyperalgesia 
(Taiwo and Levine, 1989). In addition, PGE, increases the po- 
tassium-induced cell firing in rat sensory neurons grown in ccl1 
culture (Baccaglini and Hogan, 1983). Consequently, PGE, rc- 
leased upon localized tissue trauma may facilitate the release of 
SP from sensory neurons at both the peripheral and central 
terminals. The increased release from terminals in the spinal 
cord would presumably enhance the sequence of neuronal com- 
munication for pain sensation, whereas release in the periphery 
could contribute to neurogenic inflammation (Foreman, 1987). 
The enhancement of inward Ic, caused by PGE, may also par- 
tially account for the lower threshold of firing in sensory neurons 
and for the enhanced sensitivity ofthesc neurons to other chem- 
ical mediators of pain and innammation after exposure to the 
eicosanoid. 
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